Results 1 to 10 of about 4,861,792 (337)
The radioimmunoassay of angiotensin II [PDF]
Proceedings of the Royal Society of London. Series B. Biological Sciences, 1969 Specific antibody against free angiotensin II has been raised in high titre by immunizing rabbits with angiotensin II amide (‘Hypertensin’, Ciba) adsorbed on to micro-particles of carbon. The material was injected either parenterally or directly into lymph nodes and spleen.
G. W. Boyd, J. Landon, W. S. Peart
openaire +4 more sources
Pathological Role of Angiotensin II in Severe COVID-19
TH Open, 2020 The activated renin–angiotensin system induces a prothrombotic state resulting from the imbalance between coagulation and fibrinolysis. Angiotensin II is the central effector molecule of the activated renin–angiotensin system and is degraded by the ...
Wolfgang Miesbach
doaj +2 more sources
Angiotensin II and Cardiovascular Disease: Balancing Pathogenic and Protective Pathways [PDF]
Current Issues in Molecular BiologyThe renin-angiotensin-aldosterone system (RAAS) is a hormone system that controls blood pressure and fluid and electrolyte balance. Angiotensin II, a key effector, is produced from angiotensin I by angiotensin-converting enzyme (ACE) and exerts its ...
Ulvi Bayraktutan
doaj +2 more sources
Angiotensin II—Real-Life Use and Literature Review [PDF]
MedicinaAngiotensin II is a recently introduced vasopressor, which has been available since 2017. The novelty and the relatively high cost of angiotensin II currently limit its broader application.
Andreja Möller Petrun, Andrej Markota
doaj +2 more sources
Hospital Pharmacy, 2018 Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing
Danial E. Baker, Terri L. Levien
semanticscholar +3 more sources
Upregulation of NADH/NADPH oxidase 4 by angiotensin II induces podocyte apoptosis [PDF]
Kidney Research and Clinical Practice, 2023 Background Angiotensin II induces glomerular and podocyte injury via systemic and local vasoconstrictive or non-hemodynamic effects including oxidative stress. The release of reactive oxygen species (ROS) from podocytes may participate in the development
Tae-Sun Ha +3 more
doaj +1 more source
Angiotensin converting enzyme 2 (ACE2) - the major receptor for SARS-CoV-2 virus [PDF]
Farmacja Polska, 2021 The renin-angiotensin-aldosterone system (RAS) plays a significant role in the regulation of the water and electrolyte balance. Renin from the kidneys converts angiotensinogen to angiotensin I. Angiotensin converting enzyme (ACE) catalyzes the conversion
Sonia Frankowska +3 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Background Prolonged activation of angiotensin II is the main mediator that contributes to the development of heart diseases, so converting angiotensin II into angiotensin 1‐7 has emerged as a new strategy to attenuate detrimental effects of angiotensin ...
Binh Y. Nguyen +15 more
doaj +1 more source
Circulation Research, 2020 Supplemental Digital Content is available in the text. Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 (COVID-19) in ...
Peng Zhang +43 more
semanticscholar +1 more source